We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+7.79%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$34.8B
AUM Growth
+$2.35B
(+7.2%)
Cap. Flow
+$319M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
12.19%
Holding
786
New
104
Increased
253
Reduced
218
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$336M |
| 2 |
Amgen
AMGN
|
+$176M |
| 3 |
Lockheed Martin
LMT
|
+$140M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$131M |
| 5 |
Trane Technologies
TT
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$172M |
| 2 |
RTN
Raytheon Company
RTN
|
+$154M |
| 3 |
Textron
TXT
|
+$126M |
| 4 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$109M |
| 5 |
Boeing
BA
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Industrials | 11.7% |
| 3 | Technology | 10.51% |
| 4 | Financials | 10.51% |
| 5 | Consumer Staples | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Pitney Bowes
PBI
$2.37B
| $5.25M | 0.02% |
288,796
| – | – |
|
577
Viavi Solutions
VIAV
$9.12B
| $5.23M | 0.02% |
624,793
+8,087
| +1% | +$66.5K |
|
|
PLCM
578
DELISTED
POLYCOM INC
PLCM
| $5.19M | 0.01% |
+475,000
| New | +$4.95M |
|
|
DYAX
579
DELISTED
DYAX CORPORATION
DYAX
| $5.07M | 0.01% |
739,203
+200,000
| +37% | +$908K |
|
|
MTEM
580
DELISTED
Molecular Templates, Inc.
MTEM
| $5.03M | 0.01% |
6,559
-1,831
| -22% | -$1.5M |
|
|
KMI.WS
581
CALL
DELISTED
Kinder Morgan Inc
KMI.WS
| $4.97M | 0.01% |
+1,000,000
| New | +$5.26M |
|
|
SAPE
582
DELISTED
SAPIENT CORP
SAPE
| $4.91M | 0.01% |
315,000
-60,000
| -16% | -$886K |
|
583
SBA Communications
SBAC
$19.2B
| $4.83M | 0.01% |
+60,000
| New | +$4.55M |
|
|
AAWW
584
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $4.8M | 0.01% |
104,194
+24,118
| +30% | +$1.09M |
|
|
EFII
585
DELISTED
Electronics for Imaging
EFII
| $4.75M | 0.01% |
+150,000
| New | +$4.53M |
|
|
CORV
586
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $4.73M | 0.01% |
1,332,260
| – | – |
|
587
Teradyne
TER
$57.6B
| $4.72M | 0.01% |
+286,000
| New | +$4.75M |
|
588
Ryder
R
$9.83B
| $4.71M | 0.01% |
78,900
+7,600
| +11% | +$456K |
|
|
SCHW
589
Charles Schwab
SCHW
$183B
| $4.67M | 0.01% |
220,900
-1,878,000
| -89% | -$40.8M |
|
590
Lumen
LUMN
$6.57B
| $4.63M | 0.01% |
147,675
-16,554
| -10% | -$563K |
|
591
Packaging Corp of America
PKG
$21.9B
| $4.57M | 0.01% |
+80,000
| New | +$4.33M |
|
|
ANSS
592
DELISTED
Ansys
ANSS
| $4.33M | 0.01% |
+50,000
| New | +$4.18M |
|
|
ESL
593
DELISTED
Esterline Technologies
ESL
| $4.28M | 0.01% |
53,569
-290,342
| -84% | -$23.3M |
|
|
AVNR
594
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $4.23M | 0.01% |
1,000,000
-1,300,000
| -57% | -$6.16M |
|
|
OREX
595
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $4.16M | 0.01% |
67,880
-19,720
| -23% | -$1.34M |
|
596
Bruker
BRKR
$9.57B
| $4.13M | 0.01% |
+200,000
| New | +$3.82M |
|
597
Graham Holdings Company
GHC
$5.18B
| $4.1M | 0.01% |
11,089
| – | – |
|
598
First Solar
FSLR
$22.7B
| $4.08M | 0.01% |
101,400
+4,000
| +4% | +$169K |
|
599
Abercrombie & Fitch
ANF
$4.42B
| $4.08M | 0.01% |
115,200
-1,732,922
| -94% | -$76.6M |
|
|
HSTO
600
DELISTED
Histogen Inc. Common Stock
HSTO
| $4.02M | 0.01% |
+2,000
| New | +$3.72M |
|
Similar funds
Adage Capital Partners's Q3 2013 Portfolio in Review
As of Q3 2013, Adage Capital Partners held 786 positions worth $34.8B, up 7.2% from $32.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Adage Capital Partners's Q3 2013 filing shows 104 new, 253 increased, 218 reduced and 111 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M. The largest sale was Potash Corp Of Saskatchewan, an estimated $172M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
- Adage Capital Partners's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M.
- Adage Capital Partners added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $336M increase.
- Adage Capital Partners's biggest Q3 2013 reduction was Potash Corp Of Saskatchewan, cutting an estimated $172M.
- Adage Capital Partners fully exited Raytheon Company in Q3 2013, selling an estimated $154M.
- Adage Capital Partners's ten largest holdings make up 12% of its $34.8B portfolio in Q3 2013.
- Adage Capital Partners opened 104 new positions and closed 111 in Q3 2013.
- Adage Capital Partners's portfolio value rose 7.2% quarter-over-quarter to $34.8B.
Based on Adage Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.